| Financial Year |
March 31 2023 |
| Monetary Funds |
20,598,685,288.13 |
| Held-for-trading Financial Assets |
2,647,493,500.00 |
| Notes Receivable |
48,328,673.41 |
| Accounts Receivable |
181,767,340.00 |
| Advances to Suppliers |
1,043,141,144.38 |
| Other Receivables |
4,789,652,967.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
132,592,402.19 |
| Dividend Receivable |
93,499,658.43 |
| Inventories |
96,133,770,469.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,743,213,640.52 |
| Total Current Assets |
129,296,942,022.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,394,641,103.79 |
| Investment Properties |
9,883,819,248.14 |
| Fixed Assetes |
562,949,275.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
152,181,244.02 |
| Deferred Income Tax Assets |
2,998,476,645.28 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
17,651,141,185.08 |
| Total Assets |
146,948,083,208.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,627,761.68 |
| Accounts Payable |
10,899,156,763.51 |
| Accounts Received In Advance |
46,591,383.32 |
| Employee Compensation Payable |
26,339,703.81 |
| Taxes Payable |
585,865,263.43 |
| Interest Payable |
-- |
| Dividend Payable |
41,670,452.04 |
| Other payables |
14,163,022,628.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,528,037,879.81 |
| Other Current Liabilities |
2,583,795,703.59 |
| Sub-Total of Current Liabilities |
65,843,199,558.40 |
| Long-term Loans |
30,870,313,336.89 |
| Bonds Payable |
10,637,585,911.05 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,944,336.30 |
| Deferred Income Tax Liabilities |
1,816,144,001.89 |
| Other Non-Current Liabilities |
10,270,000,000.00 |
| Sub-Total of Non-Current Liabilities |
53,800,868,871.32 |
| Total Liabilities |
119,644,068,429.72 |
| Paid-In Capital(Or Share Stock) |
2,256,537,600.00 |
| Capital Surplus |
3,256,432,645.44 |
| Surplus Reserve |
1,685,196,031.14 |
| LESS:Treasury Stock |
1,002,034,242.97 |
| Undistributed Profits |
12,853,320,190.08 |
| Minority Stockholder's Interest |
3,125,995,270.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,178,019,507.36 |
| Owner's Equity（Stockholder's Equity） |
27,304,014,778.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
146,948,083,208.05 |
